This ophthalmic biopharma firm develops sustained drug delivery therapies for eye diseases, targeting both U.S. and global markets.
When analyzing the drug delivery product pipeline, three key technologies stand out. Check out the latest market research.
Imperial neurotech spinout MintNeuro is creating specialised microchips that enable next-generation treatments for ...
Successful explantation of a corneal microlens for presbyopia and implantation of a trifocal IOL in a patient who developed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results